From: HIV-associated neurocognitive disorders at Moi teaching and referral hospital, Eldoret, Kenya
Variable | Unadjusted Estimates | Adjusted Estimates | ||
---|---|---|---|---|
OR (95% CI) | p-value | OR (95% CI) | p-value | |
Age (Years) | 1.07 (1.05, 1.10) | < 0.001 | 1.06 (1.03, 1.10) | < 0.001 |
Male | 0.58 (0.34, 0.98) | 0.042 | 0.48 (0.24, 0.97) | < 0.001 |
Education level | ||||
 Secondary vs. primary | 0.16 (0.08, 0.35) | 0.001 | 0.16 (0.07 0.38) | < 0.001 |
 Tertiary vs. Primary | 0.10 (0.04, 0.25) | 0.001 | 0.11 (0.04, 0.35) | < 0.001 |
Income ≤ Ksh/Month10000 | 0.92 (0.41, 2.08) | 0.843 | 0.54 (0.19, 1.54) | 0.252 |
Years on current HAART | 1.16 (1.05, 1.28) | 0.002 | 1.04 (0.90, 1.19) | 0.627 |
On Second line regimen | 0.41 (0.23, 0.74) | 0.003 | 0.66 (0.30, 1.43) | 0.288 |
WHO stage 3/4 vs. 1/2 | 1.49 (0.86, 2.57) | 0.152 | 2.45 (1.20, 5.01) | 0.014 |
Viral load < 1000 copies/ml | 1.40 (0.70, 2.77) | 0.340 | 0.70 (0.28, 1.73) | 0.439 |
CPE score | 1.30 (1.11, 1.53) | < 0.001 | 1.13 (0.89, 1.42) | 0.312 |
Sample Size | Â | Â | 331 | Â |